Corient Private Wealth’s Replimune Group REPL Stock Holding History

Corient Private Wealth’s Portfolio REPL Stock Details REPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-58,527	Closed	-$448K	–	3205
2026 Q1	$448K	Buy	+58,527	New	+$447K	﹤0.01%	2092

Other funds holding REPL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

RCI

Ridgeback Capital Investments Miami Beach, Florida $80.9M AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

FIS

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

Corient Private Wealth's REPL Position: Q2 2026 in Review

Corient Private Wealth sold out of Replimune Group (REPL) in Q2 2026, closing a stake of 58,527 shares — an estimated $448K sold.

Corient Private Wealth first reported a position in REPL in Q1 2026 and held it in 1 quarter. The position peaked at $448K in Q1 2026. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

Corient Private Wealth reported no remaining Replimune Group position as of Q2 2026 after selling out during the quarter.
Corient Private Wealth sold 58,527 Replimune Group shares in Q2 2026, an estimated $448K.
Corient Private Wealth first reported a position in Replimune Group in Q1 2026 and held it in 1 quarter.
Corient Private Wealth's Replimune Group position peaked at $448K in Q1 2026.
199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.